UnitedHealth Group Q3 2024 Adj. EPS $7.15 Beats $7.00 Estimate, Sales $100.800B Beat $99.279B Estimate
Portfolio Pulse from Benzinga Newsdesk
UnitedHealth Group reported its Q3 2024 earnings, with an adjusted EPS of $7.15, surpassing the estimate of $7.00. The company's sales also exceeded expectations, reaching $100.8 billion compared to the anticipated $99.279 billion.
October 15, 2024 | 9:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UnitedHealth Group's Q3 2024 earnings report shows a strong performance with both EPS and sales beating estimates, indicating positive financial health and potential stock price appreciation.
The earnings per share (EPS) of $7.15 exceeded the expected $7.00, and sales of $100.8 billion surpassed the forecast of $99.279 billion. This indicates strong financial performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100